NEXTBio Capital Management LP - Stock Holdings in 13F Filings (SEC)

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, NEXTBio Capital Management LP held in its portfolio 23 assets valued at $170,491,823 (i.e. $170.49M).

The most valuable assets in the portfolio included: TERNS PHARMACEUTICALS INC ($22.27M), PROTAGONIST THERAPEUTICS INC ($20.06M), and VOR BIOPHARMA INC ($13.08M).

The chart below shows the top 10 valuable assets, and the table below shows the top 23 valuable assets.

You can see similar for other investment managers.